Australia's Competition Regulator Authorizes Another Year Of Close Collaboration
ACCC Extends Permission For GBMA And Medicines Australia To Share Information
Executive Summary
Australian off-patent industry association GBMA and brand body Medicines Australia can continue to collaborate closely as part of work to mitigate shortages in the context of the COVID-19 pandemic, the Australian Competition and Consumer Commission has decided, extending an existing authorization by a further year.